Alex Zacharek Selected Research

Alex Zacharek Research Topics

Disease

49	Stroke (Strokes) 01/2022 - 03/2005
19	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2020 - 08/2006
7	Cognitive Dysfunction 01/2022 - 01/2019
7	Neoplasms (Cancer) 01/2008 - 09/2002
4	Neuroinflammatory Diseases 01/2022 - 01/2016
4	Fibrosis (Cirrhosis) 01/2021 - 01/2018
4	Infarction (Infarctions) 12/2018 - 01/2013
4	Carcinoma (Carcinomatosis) 01/2008 - 01/2003
4	Neoplasm Metastasis (Metastasis) 07/2006 - 09/2002
3	Body Weight (Weight, Body) 01/2022 - 01/2021
3	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022 - 01/2019
3	Cardiomegaly (Heart Hypertrophy) 01/2021 - 01/2020
3	Hypertrophy 01/2020 - 01/2017
3	Inflammation (Inflammations) 12/2019 - 01/2013
3	Diabetes Mellitus 06/2018 - 02/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2016 - 01/2013
2	Weight Loss (Weight Reduction) 01/2022 - 12/2020
2	Ischemic Stroke 01/2021 - 03/2015
2	Type 2 Diabetes Mellitus (MODY) 09/2015 - 07/2011
2	Arteriosclerosis 01/2013 - 12/2011
2	Prostatic Neoplasms (Prostate Cancer) 07/2006 - 02/2004
2	Melanoma (Melanoma, Malignant) 08/2004 - 09/2002
1	Hemorrhage 01/2022
1	Memory Disorders (Memory Loss) 06/2021
1	Ischemia 01/2021
1	Cerebral Hemorrhage 10/2019
1	Hyperlipidemias (Hyperlipidemia) 10/2019
1	Chronic Subdural Hematoma 10/2019
1	Hematoma 10/2019

Drug/Important Bio-Agent (IBA)

8	Phosphates (Orthophosphate)IBA 01/2021 - 11/2007
8	Proteins (Proteins, Gene)FDA Link 08/2019 - 08/2004
7	Angiopoietin-1IBA 01/2022 - 01/2009
6	Neuroprotective AgentsIBA 01/2022 - 01/2013
6	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2018
6	Peptides (Polypeptides)IBA 01/2022 - 01/2016
6	Therapeutic UsesIBA 01/2019 - 10/2009
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2018 - 03/2005
5	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 03/2005
4	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022 - 01/2016
4	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 06/2021 - 03/2005
4	Liver X ReceptorsIBA 01/2017 - 01/2010
4	SilverIBA 10/2014 - 09/2010
4	SynaptophysinIBA 01/2013 - 09/2010
4	Simvastatin (Zocor)FDA LinkGeneric 01/2012 - 01/2009
4	Niacin (Nicotinic Acid)FDA LinkGeneric 10/2010 - 07/2007
4	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 07/2006 - 01/2003
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2019
3	Blood Glucose (Blood Sugar)IBA 01/2021 - 11/2016
3	Apolipoproteins E (ApoE)IBA 06/2020 - 01/2017
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 10/2010
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2011
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2011
3	HDL LipoproteinsIBA 01/2016 - 10/2010
3	Nitric Oxide DonorsIBA 01/2009 - 08/2006
3	2,2'- (hydroxynitrosohydrazono)bis- ethanamineIBA 01/2009 - 08/2006
2	Insulin-Like PeptidesIBA 01/2022 - 12/2016
2	Amyloid beta-PeptidesIBA 06/2021 - 08/2019
2	Thrombin FDA Link 01/2021 - 08/2019
2	VasculotideIBA 01/2021 - 12/2018
2	LipidsIBA 12/2020 - 01/2003
2	Apolipoprotein E2IBA 06/2020 - 10/2018
2	CytokinesIBA 01/2020 - 10/2019
2	Atorvastatin (Lipitor)FDA Link 10/2019 - 01/2008
2	Amyloid (Amyloid Fibrils)IBA 08/2019 - 02/2011
2	CholesterolIBA 10/2018 - 01/2016
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2018 - 01/2013
2	GW 3965IBA 01/2017 - 01/2013
2	Luxol Fast Blue MBS (Luxol fast blue)IBA 10/2014 - 02/2011
2	HDL CholesterolIBA 01/2013 - 10/2010
2	OccludinIBA 01/2013 - 08/2006
2	Streptozocin (Streptozotocin)FDA Link 01/2013 - 12/2011
2	angiogeninIBA 01/2013 - 12/2011
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2011 - 07/2007
2	AngiopoietinsIBA 07/2011 - 08/2006
2	ChemokinesIBA 10/2009 - 01/2007
2	ThromboxanesIBA 01/2008 - 02/2004
2	Arachidonic Acid (Vitamin F)IBA 07/2006 - 01/2003
2	AcidsIBA 07/2006 - 01/2003
2	EnzymesIBA 08/2004 - 02/2004
1	Toll-Like Receptor 4IBA 01/2022
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2022
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2022
1	AlbuminsIBA 01/2022
1	Aquaporin 4IBA 06/2021
1	Interleukin-1 Receptor-Associated KinasesIBA 06/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	UbiquitinIBA 01/2021
1	NADPH Oxidase 2IBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	Pregnenolone Carbonitrile (PCN)IBA 01/2021
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 01/2021
1	Aquaporins (Water Channels)IBA 12/2019
1	Liposomes (Liposome)IBA 10/2019
1	InterleukinsIBA 10/2019
1	Pharmaceutical PreparationsIBA 10/2019
1	Tissue Plasminogen Activator (Alteplase)FDA Link 08/2019
1	FibrinIBA 08/2019

Therapy/Procedure

6	Therapeutics 09/2015 - 01/2007
2	Splenectomy 01/2020 - 01/2020